Pontus Tideman

Malmoe, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline.

The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline.

Journal: Neurology

Published: May 14, 2026

Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire.

Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: January 29, 2026

Eligibility for amyloid targeting therapies among primary care patients with cognitive symptoms.

Eligibility for amyloid targeting therapies among primary care patients with cognitive symptoms.

Journal: Alzheimer's research & therapy

Published: December 22, 2025

Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease: a prospective cohort study.

Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease: a prospective cohort study.

Journal: The Lancet. Neurology

Published: September 22, 2025

Speech-based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts.

Speech-based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 07, 2025

Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease.

Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease.

Journal: JAMA neurology

Published: May 19, 2025

Primary care detection of Alzheimer's disease using a self-administered digital cognitive test and blood biomarkers.

Primary care detection of Alzheimer's disease using a self-administered digital cognitive test and blood biomarkers.

Journal: Nature medicine

Published: March 13, 2025

Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease.

Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease.

Journal: Brain : a journal of neurology

Published: March 05, 2025

Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care.

Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care.

Journal: JAMA

Published: July 28, 2024

MRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population.

MRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population.

Journal: JAMA neurology

Published: July 28, 2024

Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform.

Plasma phospho-tau217 for Alzheimer's disease diagnosis in primary and secondary care using a fully automated platform.

Journal: Nature medicine

Published: June 02, 2024

Individualized, cross-validated prediction of future dementia using cognitive assessments in people with mild cognitive symptoms.

Individualized, cross-validated prediction of future dementia using cognitive assessments in people with mild cognitive symptoms.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 26, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026